Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Drops By 63.4%

Coloplast A/S (OTCMKTS:CLPBYGet Rating) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 4,100 shares, a drop of 63.4% from the March 31st total of 11,200 shares. Based on an average daily volume of 130,600 shares, the days-to-cover ratio is presently 0.0 days.

Several analysts recently commented on CLPBY shares. JPMorgan Chase & Co. decreased their price target on shares of Coloplast A/S from 1,038.00 to 1,033.00 in a report on Wednesday, January 19th. DNB Markets upgraded shares of Coloplast A/S from a “sell” rating to a “hold” rating in a report on Wednesday, January 26th. Finally, Barclays raised their price objective on shares of Coloplast A/S from 975.00 to 990.00 in a research report on Monday, January 10th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $1,055.67.

CLPBY traded up $0.15 during midday trading on Friday, hitting $13.77. 100,299 shares of the company’s stock traded hands, compared to its average volume of 104,551. Coloplast A/S has a one year low of $13.20 and a one year high of $18.90. The company has a market cap of $29.74 billion, a PE ratio of 45.90 and a beta of 0.28. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.29 and a quick ratio of 0.90. The stock’s fifty day simple moving average is $14.68 and its 200-day simple moving average is $15.63.

Coloplast A/S Company Profile (Get Rating)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.

Read More

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.